Retirement Guys Formula’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,342
Closed -$956K – 162
2024
Q4
$956K Buy
1,342
+64
+5% +$53.7K 0.48% 62
2024
Q3
$1.34M Buy
1,278
+94
+8% +$105K 0.62% 55
2024
Q2
$1.24M Sell
1,184
-9
-0.8% -$8.72K 0.6% 61
2024
Q1
$1.15M Buy
+1,193
New +$1.13M 0.56% 61
2022
Q1
– Sell
-461
Closed -$291K – 145
2021
Q4
$291K Buy
+461
New +$283K 0.23% 83

Other funds holding REGN

Retirement Guys Formula's REGN Position: Q1 2025 in Review

Retirement Guys Formula sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 1,342 shares — an estimated $956K sold.

Retirement Guys Formula first reported a position in REGN in Q4 2021 and held it in 5 quarters. The position peaked at $1.34M in Q3 2024. 1,292 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Retirement Guys Formula reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Retirement Guys Formula sold 1,342 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $956K.
  • Retirement Guys Formula first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Retirement Guys Formula's Regeneron Pharmaceuticals position peaked at $1.34M in Q3 2024.
  • 1,292 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Retirement Guys Formula's 13F filing for Q1 2025, filed 23 Apr 2025.